We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
NF-kB inhibitor blocks B cell development at two checkpoints.
- Authors
Biao Feng; Shuhua Cheng; Pear, Warren S.; Hsiou-Chi Liou
- Abstract
Members of the NF-kB transcription factor family are differentially expressed in the B cell lineage. Disruption of individual or two NF-kB subunits exhibits distinct defects in B lymphocyte development, activation, and survival. However, the role each NF-kB plays during B cell development has been obscured by molecular compensation. To address this issue, a transdominant form of IkBα was transduced into bone marrow cells to act as a pan-inhibitor of NF-kB using a retroviral system. While the development of T-lymphocytes and myeloid cell lineages was not grossly affected by the transduced IkBα gene, a significant reduction in the number and percentage of B lineage cells was apparent in IkBα transduced chimeric mice. IkBα expression decreased the percentage of pre-B and immature B cell subsets in the bone marrow and further impaired the development of follicular mature B cells and marginal zone B cells in the periphery. Introduction of the Bcl-X transgene completely restored the pre-B and immature B cell pool in the bone marrow. However, despite a significant improvement of overall viability of the B cell lineage, Bcl-X expression was insufficient to overcome the maturation block resulting from NF-kB inhibition. Together, our study suggests that NF-kB activity is required for two distinct checkpoints during B cell development: one is for pre-B/immature B cell viability, the other is to provide both survival and maturation signals to ensure the proper development of follicular mature B cells.
- Subjects
LYMPHOCYTE transformation; CELL proliferation; BONE marrow cells; INTERLEUKIN-6; B cell differentiation
- Publication
Medical Immunology, 2004, Vol 3, p1
- ISSN
1476-9433
- Publication type
Article
- DOI
10.1186/1476-9433-3-1